Patients with Idiopathic Pulmonary Fibrosis (IPF) and their caregivers will be randomized to receive this intervention or usual care. The intervention will include information about the disease, self-management strategies, and introduction to advanced care planning in a format with enhanced content available across multiple domains (face-to-face, printed material, digital (tablet) delivered by an interventionist. The usual care group will be provided with routine printed patient education. At the end of life, IPF patients and their caregivers experience stress, symptom burden, poor quality of life, and inadequate preparedness for end-of-life care planning. The proposed study will measure feasibility, acceptability, and impact of a Supportive Care intervention.
Idiopathic Pulmonary Fibrosis (IPF) is a disease of aging associated with intense medical and financial burden and expected to grow in incidence within the US population. Median survival from diagnosis is 3.8 years, although some patients succumb to a rapid death within 6 months. New therapies have recently become available. While these medications slow the rate of pulmonary deterioration, they have no impact on ultimate survival or quality of life. Although transplantation is an effective surgical therapy, less than 20% of patients ever receive a lung transplant. The remaining 80% have few treatment options and a likely rapidly progressive downhill course. Despite the fatal prognosis, we have found that patients and caregivers often fail to understand the poor prognosis as the disease relentlessly progresses. At the end of life, IPF patients and their caregivers experience stress, symptom burden, poor quality of life, and inadequate preparedness for end-of-life care planning. The proposed study will measure feasibility, acceptability, and impact of a Supportive Care intervention. Patients with IPF and their caregivers will be randomized to receive this intervention or usual care. The intervention will include information about the disease, self-management strategies, and introduction to advanced care planning in a format with enhanced content available across multiple domains (face-to-face, printed material, digital (tablet) delivered by an interventionist. The usual care group will be provided with routine printed patient education.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Enrollment
140
Members of this group will receive personal, enhanced printed materials, as well as face-to-face support, and digital information provided by the interventionist.
Subjects will receive their usual standard of care, including currently available printed patient material.
Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease
Pittsburgh, Pennsylvania, United States
Stress
Perceived Stress Scale at baseline and completion of study in patients and caregivers
Time frame: 3 years
Disease Preparedness
Survey to measure preparation for disease course at completion of study for patients and caregivers.
Time frame: 3 years
Knowledge
Survey to measure knowledge of IPF at baseline and study completion with patients and caregivers
Time frame: 3 years
Advance Care Planning
Survey to measure completion of advance care plan at study completion with patients
Time frame: 3 years
Quality of Dying and Death
Quality of Dying and Death for caregivers if patient deceased during study
Time frame: 3 years
Symptom Burden
Promis-29 to measure symptom burden in patients at baseline and study completion.
Time frame: 3 years
Health Related Quality of Life in IPF
ATAQ-IPF instrument to measure quality of life in patients at baseline and study completion.
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.